Skip to main content

Health and medicine/Clinical medicine/Medical diagnosis

Weaving a tale that opens in her teen years and culminates with a new job as a health science administrator at the National Institutes of Health (NIH), Amy Lossie writes about a lifelong journey – from a personal issue, to a fellowship, to working in federal policy.
Researchers say the device can be reconfigured to test for a wide range of conditions, from diagnosing cancer to monitoring diabetes.
The interdisciplinary work necessary to develop biomedical engineering devices holds great potential for collaborative research, but challenges remain in making the technology available for public use.
The 99 genomes from patients in Sierra Leone show where the 2014 outbreak originated and how strains of the virus are changing over time.

New imaging software may rival the eyes of a pathologist, according to a study in the 9 November issue of the journal Science Translational Medicine.

Researchers created the computer program, called Computational Pathologist or “C-Path,” to scan microscopic images of breast tissue for over 6000 characteristics of cancer. The software helped predict breast cancer severity in two groups of women, and could be a useful tool for gauging a patient’s chance of survival.

A new study of foot-and-mouth disease shows that cattle afflicted with the virus are only infectious for a brief window of time—about half as long as previously thought. This finding suggests that the controversial control measures used to halt the disease’s spread, such as killing large numbers of livestock, could be reduced.

The discovery is also changing the way that scientists think about infectious diseases in general.

By returning to traditional screening methods, researchers have identified an effective anti-malarial drug candidate, known as NITD609, which seems to kill the blood stages of the two major malaria parasites when administered orally, just once a day. This discovery is especially timely since researchers in Asia have begun to report a building resistance to artemisinin, the main ingredient in current malaria treatments for about 100 million patients each year.